These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 6299815)
41. Circulatory basis for the use of angiotensin converting enzyme inhibitors in hypertension and cardiac failure. Robertson JI J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S2-8. PubMed ID: 2422488 [TBL] [Abstract][Full Text] [Related]
42. [Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension]. Khadartsev AA; Logatkina AV; Terekhov IV; Bondar SS; Bondar NV Ter Arkh; 2017; 89(12):97-102. PubMed ID: 29411767 [TBL] [Abstract][Full Text] [Related]
43. Transplantation of bone marrow-derived MSCs improves renal function and Na Lira R; Oliveira M; Martins M; Silva C; Carvalho S; Stumbo AC; Cortez E; Verdoorn K; Einicker-Lamas M; Thole A; de Carvalho L Cell Tissue Res; 2017 Aug; 369(2):287-301. PubMed ID: 28374150 [TBL] [Abstract][Full Text] [Related]
44. Weight loss and the renin-angiotensin-aldosterone system. Engeli S; Böhnke J; Gorzelniak K; Janke J; Schling P; Bader M; Luft FC; Sharma AM Hypertension; 2005 Mar; 45(3):356-62. PubMed ID: 15630041 [TBL] [Abstract][Full Text] [Related]
45. Lack of correlation between human serum angiotensin converting enzyme activity and the renin-angiotensin-aldosterone system. Pedraza-Chaverrí J; Herrero B; Ibarra-Rubio ME; Cruz C; Tapia E; Pena JC Clin Chim Acta; 1990 Sep; 190(1-2):105-6. PubMed ID: 2170063 [No Abstract] [Full Text] [Related]
46. Angiotensin-converting-enzyme inhibitors in the treatment of hypertension. Coats AJ Br J Hosp Med; 1987 Dec; 38(6):531-2, 536-41. PubMed ID: 2829986 [TBL] [Abstract][Full Text] [Related]
47. The adrenal receptor for angiotensin II is altered in essential hypertension. Williams GH; Hollenberg NK; Moore TJ; Swartz SL; Dluhy RG J Clin Invest; 1979 Mar; 63(3):419-27. PubMed ID: 219037 [TBL] [Abstract][Full Text] [Related]
48. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats. Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143 [TBL] [Abstract][Full Text] [Related]
49. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension. Ideishi M; Sasaguri M; Ikeda M; Arakawa K Clin Ther; 1989; 11(4):441-51. PubMed ID: 2550133 [TBL] [Abstract][Full Text] [Related]
50. [Effect of tanshinone II(A) on expression of different components in renin-angiotensin system of left ventricles of hypertensive rats]. Yu LZ; Shi CR Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(8):1468-72. PubMed ID: 25039184 [TBL] [Abstract][Full Text] [Related]
51. Plasma renin activity in renal veins of renovascular patients. Salvetti A; Arzilli F; Sassano P; Poli L; Pedrinelli R Contrib Nephrol; 1978; 11():150-4. PubMed ID: 699583 [TBL] [Abstract][Full Text] [Related]
52. Urinary angiotensin converting enzyme 2 increases in patients with type 2 diabetic mellitus. Liang Y; Deng H; Bi S; Cui Z; A L; Zheng D; Wang Y Kidney Blood Press Res; 2015; 40(2):101-10. PubMed ID: 25791940 [TBL] [Abstract][Full Text] [Related]
53. Tonin--angiotensin II system in hypertension. Boucher R; Garcia R; Gutkowska J; Demassieux S; Genest J Clin Sci Mol Med Suppl; 1978 Dec; 4():183s-186s. PubMed ID: 215373 [TBL] [Abstract][Full Text] [Related]
54. [Influence of endogenous renin-angiotensin system on plasma aldosterone responsiveness to metoclopramide]. Iwasaki Y Nihon Naibunpi Gakkai Zasshi; 1987 Feb; 63(2):123-32. PubMed ID: 3032700 [TBL] [Abstract][Full Text] [Related]
55. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Lachurié ML; Azizi M; Guyene TT; Alhenc-Gelas F; Ménard J Circulation; 1995 Jun; 91(12):2933-42. PubMed ID: 7796503 [TBL] [Abstract][Full Text] [Related]
56. Angiotensin converting enzymes from urine of treated and untreated essential mild hypertensive patients (EHP) with diuretic: partial purification and characterization. Alves KB; Casarini DE; da Costa RH; Plavnik FL; Portela JE; Marson O Agents Actions Suppl; 1992; 38 ( Pt 3)():270-7. PubMed ID: 1334355 [TBL] [Abstract][Full Text] [Related]
57. Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker. Furuhashi M; Moniwa N; Mita T; Fuseya T; Ishimura S; Ohno K; Shibata S; Tanaka M; Watanabe Y; Akasaka H; Ohnishi H; Yoshida H; Takizawa H; Saitoh S; Ura N; Shimamoto K; Miura T Am J Hypertens; 2015 Jan; 28(1):15-21. PubMed ID: 24842388 [TBL] [Abstract][Full Text] [Related]
58. Effect of angiotensin-converting enzyme genotype on renin-angiotensin components in hypertensives. Zee RY; Schrader AP; Morris BJ Clin Chim Acta; 1996 Aug; 252(1):33-9. PubMed ID: 8814359 [TBL] [Abstract][Full Text] [Related]
59. [The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril]. Jiang M Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):342-4, 396. PubMed ID: 1668233 [TBL] [Abstract][Full Text] [Related]